Devices › Prosthesis, hip, semi-constrained, metal/polymer, porous uncemented
Device brand name · Summit hip stem hip femoral stem
Summit Por Taper Sz6 Hi Off: medical device reports filed with FDA
491 reports name it, 2005–2024. Manufacturer given most often on reports: Depuy Orthopaedics US. Product code LPH.
- 491
- device reports naming the brand
- 0% of all MAUDE reports · about 23 a year
- 0
- reports, 12 months to August 2026
- 3 in the 12 months before
- 3.9%
- classified as malfunction
- 7.5% across the product code
- 0.6%
- classified as death, as reported
- 3 reports · not verified by FDA
FDA's MAUDE database holds 491 reports that name the brand "Summit Por Taper Sz6 Hi Off" (summit hip stem hip femoral stem), received between February 2005 and October 2024; the manufacturer given most often on reports is Depuy Orthopaedics US. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, against 3 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (95.5%), malfunction (3.9%) and death (0.6%); across all prosthesis, hip, semi-constrained, metal/polymer, porous uncemented reports (product code LPH) death is recorded in 0.2% and malfunction in 7.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (28.1%), corroded (8.1%) and loss of osseointegration (7.7%). The patient problems coded most often are pain, test result and discomfort. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 90,251 reports carrying product code LPH. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 138 | 28.1% | 19.2% |
| Corrodedthe device corroded | 40 | 8.1% | 2.9% |
| Loss of osseointegration | 38 | 7.7% | 4.5% |
| Biocompatibility | 33 | 6.7% | 0.4% |
| Degraded | 22 | 4.5% | 1.7% |
| Metal shedding debris | 11 | 2.2% | 1.3% |
| Naturally worn | 11 | 2.2% | 6.1% |
| Migration or expulsion of device | 10 | 2% | 1% |
| Osseointegration problem | 10 | 2% | 2.8% |
| Fracturea broken bone | 7 | 1.4% | 4.4% |
| Noise, audible | 7 | 1.4% | 1.4% |
| Device dislodged or dislocated | 6 | 1.2% | 17% |
| Inadequacy of device shape and/or size | 4 | 0.8% | 0.3% |
| Migrationthe device moved from where it was placed | 3 | 0.6% | 1% |
| Loose or intermittent connection | 2 | 0.4% | 1.1% |
| Loss of or failure to bond | 2 | 0.4% | 0.8% |
| Malposition of device | 2 | 0.4% | 2.3% |
| Material disintegration | 2 | 0.4% | 0.3% |
| Device contaminated during manufacture or shipping | 1 | 0.2% | 0.4% |
| Difficult to removethe device was hard to remove | 1 | 0.2% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 257 | 52.3% |
| Test result | 118 | 24% |
| Discomfortdiscomfort | 116 | 23.6% |
| Foreign body reaction | 98 | 20% |
| Tissue damage | 73 | 14.9% |
| Inflammationinflammation | 57 | 11.6% |
| Host-tissue reaction | 53 | 10.8% |
| Bone fracture(s) | 48 | 9.8% |
| Limited mobility of the implanted joint | 41 | 8.4% |
| Hypersensitivity/allergic reaction | 37 | 7.5% |
| Osteolysis | 28 | 5.7% |
| Injurya physical injury | 23 | 4.7% |
| Ambulation or postural difficulties | 20 | 4.1% |
| Inadequate osseointegration | 20 | 4.1% |
| Loss of range of motion | 17 | 3.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Summit Por Taper Sz6 Hi Off | Product code LPH | All MAUDE reports |
|---|---|---|---|
| Reports | 491 | 90,251 | 26,136,888 |
| Share of that pool | — | 0.5% | 0% |
| Classified as death, per 1,000 reports | 6 | 2 | 9 |
| Classified as injury | 95.5% | 91.7% | 36.2% |
| Classified as malfunction | 3.9% | 7.5% | 62.3% |
| Filed by the manufacturer | 100% | 99.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LPH
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Unknown Hip Acetabular Liners | 4,814 | 260 | 0.2% |
| Unknown Hip Acetabular Cup | 3,215 | 106 | 0.4% |
| Apex Hole Elim Positive Stop | 1,082 | 20 | 0.4% |
| Pinn Can Bone Screw 6 5mmx25mm | 1,299 | 32 | 0% |
| Unknown Hip Femoral Stem | 4,140 | 79 | 0.8% |
| Unknown Hip Femoral Head | 5,080 | 176 | 0.7% |
| Pinn Can Bone Screw 6 5mmx20mm | 1,075 | 19 | 0.3% |
| Pinn Can Bone Screw 6 5mmx30mm | 981 | 22 | 0.3% |
| Altrx Neut 36idx52od | 638 | 23 | 0% |
| UNK Hip Femoral Head Ceramic | 720 | 126 | 0.1% |
| Unknown Hip | 2,306 | 5 | 1.9% |
| Trident 0 X3 Insert 36mm Id | 585 | 0 | 0.2% |
| Altrx Neut 36idx54od | 553 | 23 | 0% |
| Altrx Neut 32idx50od | 552 | 21 | 0% |
| Altrx +4 10d 36idx52od | 544 | 17 | 0.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Summit Por Taper Sz6 Hi Off reports
How many FDA reports name Summit Por Taper Sz6 Hi Off?
491 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (95.5%), malfunction (3.9%) and death (0.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (28.1%), corroded (8.1%), loss of osseointegration (7.7%), biocompatibility (6.7%) and degraded (4.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Summit Por Taper Sz6 Hi Off was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.